PT Saptausaha Gemilangindah Tbk (SAGE)
Jul 31, 2025 - SAGE was delisted (reason: acquired by SUPN)
8.68
-0.02 (-0.23%)
Inactive · Last trade price
on Jul 30, 2025
Sage Therapeutics Employees
PT Saptausaha Gemilangindah Tbk had 23 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$10,191
Profits / Employee
-$3,391
Market Cap
21.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 23 | 0 | - |
| Dec 31, 2023 | 23 | 0 | - |
| Dec 31, 2022 | 23 | 4 | 21.05% |
| Dec 31, 2021 | 19 | - | - |
SAGE News
- 2 months ago - Sage Therapeutics Announces Second Quarter 2025 Financial Results - Business Wire
- 2 months ago - SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE - Business Wire
- 3 months ago - Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 3 months ago - These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News - Benzinga
- 3 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - Accesswire
- 3 months ago - Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 3 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - PRNewsWire
- 3 months ago - Sage Therapeutics Stock Soars 35% After Sale to Supernus. What We Know. - Barrons